DNA sequencing is the process of determining the linear order of nucleotides in a DNA section which allows the scientists and researchers to know the exact code in a DNA molecule. There are different modern sequencing technologies such as Roche 454 sequencing, SOLiD sequencing, Illumina sequencing and Ion torrent: Proton/PGM sequencing. They are cost-effective and give accurate results, thereby finding applications in drug discoveries, personalized medicines, diagnostics, and agriculture and animal researches. According to the latest report by IMARC Group, titled “DNA Sequencing Products Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2018-2023”, the global DNA sequencing products market reached a value of US$ 3 Billion in 2017.
The Human Genome Project (HGP) was the first joint initiative by various organizations to map the human genome which took nearly 13 years to complete along with a huge investment. Since the completion of this project, a major transformation has been witnessed in the DNA sequencing technologies. New-age technologies have been developed such as 454 sequencing or Illumina sequencing which involve low cost and deliver results in shorter period of time. Owing to the declining costs of sequencing, many countries are investing in the process which impels the growth prospects of the market. Further, the market is anticipated to be boosted by the rising demand for personalized medicines. On account of these factors, the market is expected to reach a value of US$ 8 Billion by 2023, exhibiting a CAGR of around 15% during 2018-2023.
The report has segmented the global DNA sequencing products market on the basis of product type. Currently, consumables and reagents dominate the market, followed by equipment. The market is also segregated on the basis of applications covering research organizations, and hospitals, pharmaceutical and life science companies. The research organizations sector is the largest application area, accounting for the majority of the global share. Region-wise, North America is the leading market for DNA sequencing products. It is followed by Europe, Asia Pacific, Latin America, and Middle East and Africa. On analysing the competitive landscape of the market, the key players found are Illumina Inc., Thermo Fisher Scientific Inc., Roche Diagnostics, Pacific Biosciences of California, Inc. and Beckman Coulter.
This report provides a deep insight into the global DNA sequencing products market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for entrepreneurs, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the DNA sequencing products market in any manner.
Key Questions Answered in This Report:
- How has the global DNA sequencing products market performed so far and how will it perform in the coming years?
- What are the key regions in the global DNA sequencing products market?
- Which are the popular products in the global DNA sequencing products market?
- What are the key application segments in the global DNA sequencing products market?
- What are the various stages in the value chain of the global DNA sequencing products market?
- What are the key driving factors and challenges in the global DNA sequencing products market?
- What is the structure of the global DNA sequencing products market and who are the key players?
- What is the degree of competition in the global DNA sequencing products market?